Oncimmune

Oncimmune

Operates as a cancer detection company. The Company focuses on the development of autoantibody assay technologies that allow cancer detection earlier than other methods. Learn more

Launch date
Employees
Market cap
$20.6m
Enterprise valuation
$26m (Public information from Sep 2024)
Company register number 04606727
Leeds England (HQ)
Authorizing premium user...